In-vivo Evaluation and Characterization of Novel In-Situ Gelling System as Controlled Delivery System Containing Ciprofloxacin for Ocular Drug Delivery
Objectives: The purpose of this research was to develop the micro emulsion-based in situ gelling systems containing Ciprofloxacin for prophylaxis and treatment of the posterior segment diseases like endophthalmitis.
Methods: Ciprofloxacin was encapsulated in small droplets owing to form microemulsion, and then the formed droplets were dispersed in a polymer solution that converted into a gel upon triggered by the electrolyte present in the tear fluid.
Results: The formulation approach provides better absorption, penetration, retention, and improves the bioavailability of the drug. The average concentration reached into vitreous humor from topical microemulsion in situ gelling formulation was ~0.4 µg/ml, which is far more than the concentration required for therapeutic effect (i.e. >0.047 µg/ml or >MIC90 for S. Epidermidis, a pathogen commonly responsible to cause endophthalmitis).
Conclusion: Thus, novel micro emulsion-based in situ gelling formulation could be a potential drug delivery system for the treatment of posterior segment diseases like endophthalmitis.
Keywords: Microemulsion, ciprofloxacin, endophthalmitis, ocular, infection, in situ
2. Sumedha N, Chandrakant L et al, Current Trends in Novel Drug Delivery an OTC Perspective. Pharma Times, 2010; 42:17-23.
3. Vandamme TF, Microemulsions as ocular drug delivery systems: recent developments and future challenges. Progress in Retinal and Eye Research, 2002; 21: 15-34.
4. Kumar K, Senthil D, Saravanan, Microemulsions as carrier for novel drug delivery: A review, Int J Pharma Sci Rev and Res, 2011; 10:37-45.
5. Peltola S, Saarinen P, Kiesvaara J, et al, Microemulsions for topical delivery of estradiol. Int. J. Pharm, 2003; 254:99-107.
6. Huang C, Xueling C, Dandong D, et al, Microemulsion-based hydrogel formulation of ibuprofen for topical delivery. Int J Pharmaceutics, 2006; 351: 52-58.
7. Spielen P, Homar M, Zupancic-Valant A, et al. Sodium ascorbyl phosphate in topical microemulsions. Int. J. Pharm. 2003; 256:65-73.
8. Suthar M, Modi JD, Patel MP, et al, Microemulsion-Based gel formulation and evaluation of tretinoin for topical delivery. Int J Pharma res, 2009; 1(4):28-34.
9. Lawrence MJ, Surfactant systems: microemulsion and vesicles as vehicles for drug delivery. Eur J Drug Metab Pharmacokin, 1994; 3:257-269.
10. Sariciaux MJ, Alan L, Sado PA, Using microemulsion for drug delivery of therapeutic peptides. Int J Pharmaceutics, 1995; 12:127-136.
11. Swenson EC, Curatolo W, Intestinal permeability enhancement for proteins, peptides, and other polar drugs: mechanism and potential toxicity. Adv Drug Del Rev, 1992; 8:39-42.
12. Kyung MP, Chong-Kook K, Preparation and evaluation of flurbiprofen- loaded microemulsion for parenteral delivery. Int J Pharma, 1999; 181:173-79.
13. Lee JM, Park KM, Lim SJ, et al, Microemulsion formulation of clonic acid: solubility enhancement and pain reduction. J Pharmacy Pharmacol, 2002; 54:43-49.
14. Rhee YS, Park CW, Nam TY, et al, Formulation of parenteral microemulsion containing itraconazole. Archives of Pharmacal Res, 2007; 30:114-23.
15. Ryoo HK, Park CW, Chi SC, et al, Development of propofol loaded microemulsion systems for parenteral delivery. Archives of Pharmacal Res. 2005; 28:1400-04.
16. Hwang SR, Lim SJ, Park JS, et al, Phospholipids based microemulsion formulation for all-trans-retinoic acid for parenteral administration. Int J Pharmaceutics, 2004; 276:175-83.
17. Zhao X, Chen D, Gao P, et al, Synthesis of Ibuprofen eugenol ester and its microemulsion formulation for parenteral delivery. Chem Pharma Bulletin, 2005; 53:1246-50.
18. Jumma M, Muller BW, The effect of oil components and homogenization conditions on the physicochemical properties and stability of parenteral fat emulsions. Int J Pharmaceutics, 1998; 163: 81-89.
19. Kriwet K, Muller-Goymann CC, Diclofenac release from phospholipid drug systems and permeation through excised human stratum corneum. Int J Pharmaceutics, 1995; 125:231-42.
20. Trotta M, Morel S, Gasco MR, Effect of oil phase composition on the skin permeation of felodipine from w/o microemulsions. Pharmazie, 1997; 52: 50-53.
21. Chen H, Chang X, Weng T, et al, A study of microemulsion systems for transdermal delivery of triptolide. J Control Release, 2004; 98:427-36.
22. Gupta RR, Jain SK, Varshney M, Water-in-oil microemulsion as a penetration enhancer in transdermal drug delivery of 5-fluorouracil. Colloids Surfaces B: Biointerfaces, 2005; 41:25-32.
23. Elena P, Paola S, Maria RG, Transdermal permeation of apomorphine through hairless mouse skin from microemulsions. Int J Pharmaceutics, 2001; 226:47-51.
24. Rhee YS, Choi JG, Park ES, et al, Transdermal delivery of ketoprofen using microemulsions. Int J Pharmaceutics, 2001; 228:161-70
25. Yuan Y, Li SM, Mo FK, et al, Investigation of microemulsion system for transdermal delivery of meloxicam. Int J Pharmaceutics, 2006; 321:117-23.
26. Li H, Pan WS, Li JY, Preparation, evaluation, and NMR characterization of vinpocetine microemulsion for transdermal delivery. Drug Dev Ind Pharm, 2004; 30: 657-66.
27. Kreilgaard M, Influence of microemulsion on cutaneous drug delivery. Advanced Drug Del Rev, 2002; 54:77-98.
28. Alana R, Rades T, Nicoll J, et al, W/O microemulsions for ocular delivery: Evaluation of ocular irritation and precorneal retention. J Controlled Release. 2006; 111:145-52.
29. HaBe A, Keipert S, Development and characterization of microemulsions for ocular application. Eur J Pharmaceu Biopharma.1997; 43: 179-183.
30. Vandamme TF, Microemulsions as ocular drug delivery systems: recent developments and future challenges. Progress in Retinal Eye Res. 2002; 21:15-34.
31. Newman MG, Takei H, Carranza FA, Clinical Periodontology, 9th edition, Philadelphia: WB Saunders, 2002.
32. Houshmand B, Rafiei A, Hajilooi M, et al, E-selectin and L-selectin polymorphisms in patients with periodontitis. J Periodont Res, 2009; 44:88-93.
33. Talegaonkar S, Azeem A, Ahmad FJ, et al, Microemulsions: A Novel Approach to Enhanced Drug Delivery. Recent Patents on Drug Delivery & Formulation. 2008; 2:238-57.
34. Lily IL, Nandi I, Kim KH, Development of an ethyl laurate based microemulsion for rapid onset of intranasal delivery of diazepam. Int J Pharmaceu, 2002; 237:77-85.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).